Skip to content
The Nexus
DossierENTITY

IMUX

Coverage of IMUX in the Nexus archive.

Earliest in view: Aug 11 · 10:35 UTCMost recent: Aug 11 · 10:35 UTC
Co-mentioned in this coverage
Immunicorganization1New Yorkplace1APorganization1Zacks Investment Researchorganization1Automated Insightsorganization1
Recent coverage
  • BUSINESSAug 11 · 10:35 UTCWTOP DC
    Immunic: Q2 Earnings Snapshot

    Immunic, Inc. reported a loss of $34.1 million in its second quarter, reporting 80 cents per share loss. These results surpassed Wall Street expectations. The average estimate from six analysts surveyed by Zacks Investment Research was for a loss of $1.24 per share.

IMUX · Dossier · The Nexus